Novorapid and glycosylated haemoglobin increased Patient Reports February 12, 2012

Novorapid Side Effects Report #6122670-2
Novorapid side effect was reported by a Health Professional from FRANCE on Mar 09, 2009. Female patient, 56 years of age, weighting 114.6 lb, was diagnosed with type 1 diabetes mellitus, adrenal insufficiency, hypothyroidism and was treated with Novorapid. After drug was administered, patient experienced the following side effects: glycosylated haemoglobin increased, hypertriglyceridaemia, hypoglycaemic coma, leukocytosis, osteopenia, suicide attempt. Novorapid dosage: unknown. During the same period patient was treated with LANTUS, FLUDROCORTISONE, HYDROCORTISONE, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Novorapid Side Effects Report #5580104-0
Novorapid side effect was reported by a Physician from JAPAN on Dec 21, 2007. Female patient, 30 years of age, weighting 116.8 lb, was diagnosed with type 1 diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: abortion , blood glucose fluctuation, glycosylated haemoglobin increased, pregnancy . Novorapid dosage: unknown. During the same period patient was treated with NOVOLIN N, LANTUS. Patient recovered.

Novorapid Side Effects Report #5023763-3
Novorapid side effect was reported by a Consumer or non-health professional from JAPAN on May 29, 2006. Female patient, 77 years of age, weighting 110.2 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: anti-insulin antibody positive, glycosylated haemoglobin increased, hyperglycaemia, hypoglycaemia. Novorapid dosage: unknown. During the same period patient was treated with NOVOLIN R, BASEN. Patient was hospitalized. Patient recovered.

Novorapid Side Effects Report #6100619-6
Novorapid side effect was reported by a Pharmacist from SWITZERLAND on Feb 20, 2009. Male patient, 52 years of age, weighting 172.0 lb, was diagnosed with insulin-requiring type 2 diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: blood glucose increased, fatigue, glycosylated haemoglobin increased, hypertension, visual impairment. Novorapid dosage: unknown. During the same period patient was treated with NOVORAPID FLEXPEN, LANTUS, GLUCOPHAGE, COAPROVEL, ATENOLOL. Patient recovered.


Novorapid Side Effects Report #4916854-6
Novorapid side effect was reported by a Consumer or non-health professional from JAPAN on Dec 13, 2005. Female patient, 59 years of age, weighting 101.4 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with Novorapid. After drug was administered, patient experienced the following side effects: abdominal pain , allodynia, back pain , blood glucose increased, burning sensation, face oedema, glycosylated haemoglobin increased, hyperaesthesia, nerve injury. Novorapid dosage: unknown. During the same period patient was treated with EUGLUCON, AMITRIPTYLINE HYDROCHLORIDE, NOVORAPID CHU FLEXPEN, BASEN, PENFILL N CHU. Patient was hospitalized. Patient recovered.

Novorapid Side Effects Report #4993363-X
Novorapid side effect was reported by a Physician from UNITED STATES on Mar 09, 2006. Female patient, 13 years of age, weighting 121.3 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with Novorapid. After drug was administered, patient experienced the following side effects: diabetic ketoacidosis, glycosylated haemoglobin increased, loss of consciousness, medical device complication. Novorapid dosage: unknown. During the same period patient was treated with SYNTHROID. Patient recovered.

Novorapid Side Effects Report #4597690-X
Novorapid side effect was reported by a Physician from on Dec 24, 2004. Female patient, 55 years of age, weighting 97.00 lb, was diagnosed with diabetes mellitus, ill-defined disorder and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, glycosylated haemoglobin increased, hepatic function abnormal, hepatomegaly. Novorapid dosage: unknown. During the same period patient was treated with NOVOLIN N, RABEPRAZOLE, PRIMPERAN, HUMULIN. Patient was hospitalized. Patient recovered.

Novorapid Side Effects Report #4617244-6
Novorapid side effect was reported by a Physician from on Dec 24, 2004. Female patient, 55 years of age, weighting 97.00 lb, was diagnosed with diabetes mellitus, ill-defined disorder and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, glycosylated haemoglobin increased, hepatic function abnormal, hepatomegaly. Novorapid dosage: unknown. During the same period patient was treated with NOVOLIN N, RABEPRAZOLE, PRIMPERAN, HUMULIN. Patient was hospitalized. Patient recovered.

Novorapid Side Effects Report #5022327-5
Novorapid side effect was reported by a Physician from JAPAN on May 16, 2006. Female patient, 39 years of age, weighting 97.00 lb, was diagnosed with diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: burning sensation, chest discomfort, erythema, glycosylated haemoglobin increased, hot flush, hypoaesthesia oral, injection site erythema, injection site induration. Novorapid dosage: unknown. During the same period patient was treated with THYRADIN S, ONEALFA, CYANOCOBALAMIN, BAKTAR, NOVOLIN N, NOVOLIN R, ALESION. Patient was hospitalized. Patient recovered.


Novorapid Side Effects Report #5195469-1
Novorapid side effect was reported by a Physician from JAPAN on Mar 31, 2005. Male patient, 68 years of age, weighting 143.3 lb, was diagnosed with diabetes mellitus, diabetes mellitus insulin-dependent and was treated with Novorapid. After drug was administered, patient experienced the following side effects: anti-insulin antibody positive, glycosylated haemoglobin increased. Novorapid dosage: unknown. During the same period patient was treated with NOVOLIN N, NOVOLIN R. Patient was hospitalized. Patient recovered.